Comment on "Reply to Mortality Rate in Breast Implant Surgery: Is an Additional Procedure Worthwhile to Mitigate BIA-ALCL Risk"

Fabio Santanelli di Pompeo^{1

2}, Michail Sorotos^{3

4}, Mark W Clemens⁵, Guido Paolini^{3

4}, Paolo Anibaldi⁴, Marina Davoli^{6

7}, Giovanni Baglio⁷, Luigi Pinnarelli⁶, Margherita Ferranti⁶, Francesco Cerza⁷, Stefano Domenico Cicala⁷, Guido Firmani³

Affiliations

¹ Faculty of Medicine and Psychology, Sapienza University of Rome, Azienda Ospedaliera Sant'Andrea - U.O.D. Chirurgia Plastica, Via di Grottarossa, 1035-1039, 00189, Rome, Italy. fabio.santanelli@uniroma1.it.
² Sant'Andrea University Hospital, Rome, Italy. fabio.santanelli@uniroma1.it.
³ Faculty of Medicine and Psychology, Sapienza University of Rome, Azienda Ospedaliera Sant'Andrea - U.O.D. Chirurgia Plastica, Via di Grottarossa, 1035-1039, 00189, Rome, Italy.
⁴ Sant'Andrea University Hospital, Rome, Italy.
⁵ The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
⁶ Lazio Regional Health Service, Rome, Italy.
⁷ Italian National Agency for Regional Healthcare Services (AGENAS), Italian Ministry of Health, Rome, Italy.

Comment

Fabio Santanelli di Pompeo et al. Aesthetic Plast Surg. 2023 Jun.

. 2023 Jun;47(3):930-933.

doi: 10.1007/s00266-023-03324-z. Epub 2023 Mar 29.

¹ Faculty of Medicine and Psychology, Sapienza University of Rome, Azienda Ospedaliera Sant'Andrea - U.O.D. Chirurgia Plastica, Via di Grottarossa, 1035-1039, 00189, Rome, Italy. fabio.santanelli@uniroma1.it.
² Sant'Andrea University Hospital, Rome, Italy. fabio.santanelli@uniroma1.it.
³ Faculty of Medicine and Psychology, Sapienza University of Rome, Azienda Ospedaliera Sant'Andrea - U.O.D. Chirurgia Plastica, Via di Grottarossa, 1035-1039, 00189, Rome, Italy.
⁴ Sant'Andrea University Hospital, Rome, Italy.
⁵ The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
⁶ Lazio Regional Health Service, Rome, Italy.
⁷ Italian National Agency for Regional Healthcare Services (AGENAS), Italian Ministry of Health, Rome, Italy.

No abstract available

Comment on

Reply to: Mortality Rate in Breast Implant Surgery: Is an Additional Procedure Worthwhile to Mitigate BIA-ALCL Risk?
Rocco N, Andree C, Barnea Y, Catanuto G, Celet Ozden B, De Vita R, Hamdi M, Harris P, Mallucci P, Montemurro P, Pacifico M, Perin LF, Pompei S, Rancati A, Stan C, Nava MB. Rocco N, et al. Aesthetic Plast Surg. 2023 Jun;47(3):927-929. doi: 10.1007/s00266-023-03251-z. Epub 2023 Jan 20. Aesthetic Plast Surg. 2023. PMID: 36670305 No abstract available.

1. Oreskes N, Conway EM (2010) Merchants of doubt: how a handful of scientists obscured the truth on issues from tobacco smoke to global warming. Bloomsbury Press, USA
1. Rocco N, Andree C, Barnea Y et al (2023) Reply to: mortality rate in breast implant surgery: is an additional procedure worthwhile to mitigate BIA-ALCL risk? Aesthetic Plast Surg. https://doi.org/10.1007/s00266-023-03251-z - DOI - PubMed
1. SCHEER (Scientific Committee on Health, Environmental and Emerging Risks) (2021) Final opinion on the safety of breast implants in relation to anaplastic large cell lymphoma. European Commission. https://health.ec.europa.eu/system/files/2022-08/scheer_o_018.pdf (Accessed: January 23, 2023).
1. United States Food and Drug Administration (2019) FDA takes action to protect patients from risk of certain textured breast implants; requests Allergan voluntarily recall certain breast implants and tissue expanders from market. Accessed online at https://www.fda.gov/news-events/press-announcements/fda-takes-action-pro...
1. Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM) (2021) Withdraw certain macro-textured implants of an equivalent texture to Allergan brand implants. Agence nationale de sécurité du médicament et des produits de santé Website. Accessed online at https://ansm.sante.fr/uploads/2021/12/09/20211209-ra-2020-eng.pdf